if FDA approves on May 1st, in long term (3 years), it will be w

since their personalized vaccine can virtually be applied to any cancer indication. DNDN stopped the trails on Breast Cancer, etc on year 2007 after FDA declined their vaccine on May 2007, even though Advisory Committee voted favor on April 2007. Then they shorted finance to support other cancer trails. they cut all other budgets and only focused on Prostate Cancer trail later on. This 2nd Phase 3 in last year showed the exact same result as that of 1st Phase 3 in year 2007.